We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1776
DELISTED
Veradigm Inc. Common Stock
MDRX
| $381K | ﹤0.01% |
25,710
-5,260
| -17% | -$98.3K |
|
1777
Brookfield Renewable
BEPC
$6.17B
| $378K | ﹤0.01% |
+10,605
| New | +$392K |
|
1778
Alpha Metallurgical Resources
AMR
$1.95B
| $376K | ﹤0.01% |
2,909
+1,393
| +92% | +$211K |
|
|
APLS
1779
DELISTED
Apellis Pharmaceuticals
APLS
| $376K | ﹤0.01% |
+8,307
| New | +$379K |
|
1780
RE/MAX Holdings
RMAX
$243M
| $376K | ﹤0.01% |
15,336
+6,843
| +81% | +$166K |
|
1781
DigitalOcean
DOCN
$15.3B
| $375K | ﹤0.01% |
9,063
-7,036
| -44% | -$314K |
|
1782
Middlesex Water
MSEX
$1.09B
| $375K | ﹤0.01% |
4,279
-3,587
| -46% | -$322K |
|
1783
Upbound Group
UPBD
$1.12B
| $374K | ﹤0.01% |
19,253
+7,222
| +60% | +$180K |
|
1784
Hilton Grand Vacations
HGV
$3.31B
| $372K | ﹤0.01% |
10,579
-3,205
| -23% | -$143K |
|
1785
Hyatt Hotels
H
$16B
| $370K | ﹤0.01% |
5,085
-616
| -11% | -$53.4K |
|
1786
Companhia Siderúrgica Nacional
SID
$1.19B
| $369K | ﹤0.01% |
125,917
+17,961
| +17% | +$75.7K |
|
1787
LendingTree
TREE
$453M
| $369K | ﹤0.01% |
8,482
+2,784
| +49% | +$206K |
|
|
BGFV
1788
DELISTED
Big 5 Sporting Goods
BGFV
| $368K | ﹤0.01% |
32,841
-8,883
| -21% | -$121K |
|
1789
Domo
DOMO
$189M
| $367K | ﹤0.01% |
13,217
-34,163
| -72% | -$1.25M |
|
1790
NETGEAR
NTGR
$627M
| $365K | ﹤0.01% |
19,733
-6,727
| -25% | -$137K |
|
1791
Wabash National
WNC
$510M
| $363K | ﹤0.01% |
+26,726
| New | +$386K |
|
|
ESTE
1792
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $362K | ﹤0.01% |
26,503
-31,332
| -54% | -$493K |
|
1793
Veeco
VECO
$3.02B
| $361K | ﹤0.01% |
18,590
+3,954
| +27% | +$87.7K |
|
1794
Sally Beauty Holdings
SBH
$1.57B
| $360K | ﹤0.01% |
31,576
+91
| +0.3% | +$1.32K |
|
1795
Magnachip Semiconductor
MX
$134M
| $358K | ﹤0.01% |
24,638
-2,776
| -10% | -$47.7K |
|
1796
Opendoor
OPEN
$3.38B
| $358K | ﹤0.01% |
82,288
+67,433
| +454% | +$444K |
|
1797
Ultrapar
UGP
$6.42B
| $358K | ﹤0.01% |
152,134
| – | – |
|
1798
AtriCure
ATRC
$2.12B
| $356K | ﹤0.01% |
8,703
-5,219
| -37% | -$247K |
|
1799
BRC Group Holdings
RILY
$292M
| $356K | ﹤0.01% |
8,418
-10,545
| -56% | -$553K |
|
1800
Weatherford International
WFRD
$6.66B
| $356K | ﹤0.01% |
+16,800
| New | +$535K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.